mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.8 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |